| Style | Citing Format |
|---|---|
| MLA | Abdolshahi A, et al.. "From Microbes to Medicine: How Microbiota Profiling Is Shaping the Future of Cancer Therapy." Gene Reports, vol. 42, no. , 2026, pp. -. |
| APA | Abdolshahi A, Naderian R, Tahmasebi H, Paraandavaji E, Hemmati MA, Kashanipoor S, Eslami M (2026). From Microbes to Medicine: How Microbiota Profiling Is Shaping the Future of Cancer Therapy. Gene Reports, 42(), -. |
| Chicago | Abdolshahi A, Naderian R, Tahmasebi H, Paraandavaji E, Hemmati MA, Kashanipoor S, Eslami M. "From Microbes to Medicine: How Microbiota Profiling Is Shaping the Future of Cancer Therapy." Gene Reports 42, no. (2026): -. |
| Harvard | Abdolshahi A et al. (2026) 'From Microbes to Medicine: How Microbiota Profiling Is Shaping the Future of Cancer Therapy', Gene Reports, 42(), pp. -. |
| Vancouver | Abdolshahi A, Naderian R, Tahmasebi H, Paraandavaji E, Hemmati MA, Kashanipoor S, et al.. From Microbes to Medicine: How Microbiota Profiling Is Shaping the Future of Cancer Therapy. Gene Reports. 2026;42():-. |
| BibTex | @article{ author = {Abdolshahi A and Naderian R and Tahmasebi H and Paraandavaji E and Hemmati MA and Kashanipoor S and Eslami M}, title = {From Microbes to Medicine: How Microbiota Profiling Is Shaping the Future of Cancer Therapy}, journal = {Gene Reports}, volume = {42}, number = {}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Abdolshahi A AU - Naderian R AU - Tahmasebi H AU - Paraandavaji E AU - Hemmati MA AU - Kashanipoor S AU - Eslami M TI - From Microbes to Medicine: How Microbiota Profiling Is Shaping the Future of Cancer Therapy JO - Gene Reports VL - 42 IS - SP - EP - PY - 2026 ER - |